At close: November 29 at 3:48 PM GMT+5:30
Key Executives
Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in INR.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Ms. Shilpa Shashank Joshi | CFO & Whole-Time Director | -- | -- | 1969 |
| Ms. Chandni Maru | Company Secretary & Compliance Officer | -- | -- | -- |
| Mr. Falin Majmudar | WholeTime Director | -- | -- | 1968 |
| Dr. Vasant Narasimhan M.D. | Chief Executive Officer of Novartis | -- | -- | 1976 |
Novartis India Limited
Inspire BKC
7th Floor Bandra-Kurla Complex Bandra (East)
Mumbai, 400051
India
- Sector:
- Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
- Full Time Employees:
- 62
Description
Novartis India Limited operates as a healthcare company in India. The company offers therapeutic products in the areas of bone and pain products under the Voveran brand; transplantation immunology products under the Simulect, Certican, Sandimmun, Neoral, and Myfortic brands. It also offers neurosciences products under the Tegrital and Exelon brands. Novartis India Limited was incorporated in 1947 and is based in Mumbai, India. The company is a subsidiary of Novartis AG.
Corporate Governance
Novartis India Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
January 23, 2025 at 10:59 AM UTC - January 27, 2025 at 12:00 PM UTC
Novartis India Limited Earnings Date
Recent Events
July 23, 2024 at 12:00 AM UTC
Ex-Dividend Date